Log in
Enquire now
‌

US Patent 11180563 FLT3 binding proteins and methods of use

Patent 11180563 was granted and assigned to Harpoon Therapeutics on November, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Harpoon Therapeutics
Harpoon Therapeutics
Current Assignee
Harpoon Therapeutics
Harpoon Therapeutics
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11180563
Date of Patent
November 23, 2021
Patent Application Number
17180435
Date Filed
February 19, 2021
Patent Citations Received
‌
US Patent 12084518 Trispecific binding proteins and methods of use
0
‌
US Patent 11623958 Single chain variable fragment CD3 binding proteins
‌
US Patent 11607453 Mesothelin binding proteins
‌
US Patent 11976125 B cell maturation antigen binding proteins
0
‌
US Patent 11535668 Inducible monovalent antigen binding protein
Patent Primary Examiner
‌
Stephen L. Rawlings
Patent abstract

Provided herein are FLT3 binding proteins, pharmaceutical compositions comprising such proteins or fragments thereof, as well as nucleic acids, recombinant expression vectors and host cells for making such FLT3 binding proteins. Also disclosed are methods of using the disclosed FLT3 binding proteins in the prevention, and/or treatment of diseases, conditions and disorders.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11180563 FLT3 binding proteins and methods of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.